The INSPIRE Bio-Resource Research Platform for Healthy Aging and Geroscience: Focus on the Human Translational Research Cohort (The INSPIRE-T Cohort).
Gerosciences
biological aging
biology of aging
integrated care
intrinsic capacity
translational research on aging
Journal
The Journal of frailty & aging
ISSN: 2260-1341
Titre abrégé: J Frailty Aging
Pays: France
ID NLM: 101604797
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
12
2
2021
pubmed:
13
2
2021
medline:
18
2
2021
Statut:
ppublish
Résumé
The Geroscience field focuses on the core biological mechanisms of aging, which are involved in the onset of age-related diseases, as well as declines in intrinsic capacity (IC) (body functions) leading to dependency. A better understanding on how to measure the true age of an individual or biological aging is an essential step that may lead to the definition of putative markers capable of predicting healthy aging. The main objective of the INStitute for Prevention healthy agIng and medicine Rejuvenative (INSPIRE) Platform initiative is to build a program for Geroscience and healthy aging research going from animal models to humans and the health care system. The specific aim of the INSPIRE human translational cohort (INSPIRE-T cohort) is to gather clinical, digital and imaging data, and perform relevant and extensive biobanking to allow basic and translational research on humans. The INSPIRE-T cohort consists in a population study comprising 1000 individuals in Toulouse and surrounding areas (France) of different ages (20 years or over - no upper limit for age) and functional capacity levels (from robustness to frailty, and even dependency) with follow-up over 10 years. Diversified data are collected annually in research facilities or at home according to standardized procedures. Between two annual visits, IC domains are monitored every 4-month by using the ICOPE Monitor app developed in collaboration with WHO. Once IC decline is confirmed, participants will have a clinical assessment and blood sampling to investigate markers of aging at the time IC declines are detected. Biospecimens include blood, urine, saliva, and dental plaque that are collected from all subjects at baseline and then, annually. Nasopharyngeal swabs and cutaneous surface samples are collected in a large subgroup of subjects every two years. Feces, hair bulb and skin biopsy are collected optionally at the baseline visit and will be performed again during the longitudinal follow up. Recruitment started on October 2019 and is expected to last for two years. Bio-resources collected and explored in the INSPIRE-T cohort will be available for academic and industry partners aiming to identify robust (set of) markers of aging, age-related diseases and IC evolution that could be pharmacologically or non-pharmacologically targetable. The INSPIRE-T will also aim to develop an integrative approach to explore the use of innovative technologies and a new, function and person-centered health care pathway that will promote a healthy aging.
Sections du résumé
BACKGROUND
BACKGROUND
The Geroscience field focuses on the core biological mechanisms of aging, which are involved in the onset of age-related diseases, as well as declines in intrinsic capacity (IC) (body functions) leading to dependency. A better understanding on how to measure the true age of an individual or biological aging is an essential step that may lead to the definition of putative markers capable of predicting healthy aging.
OBJECTIVES
OBJECTIVE
The main objective of the INStitute for Prevention healthy agIng and medicine Rejuvenative (INSPIRE) Platform initiative is to build a program for Geroscience and healthy aging research going from animal models to humans and the health care system. The specific aim of the INSPIRE human translational cohort (INSPIRE-T cohort) is to gather clinical, digital and imaging data, and perform relevant and extensive biobanking to allow basic and translational research on humans.
METHODS
METHODS
The INSPIRE-T cohort consists in a population study comprising 1000 individuals in Toulouse and surrounding areas (France) of different ages (20 years or over - no upper limit for age) and functional capacity levels (from robustness to frailty, and even dependency) with follow-up over 10 years. Diversified data are collected annually in research facilities or at home according to standardized procedures. Between two annual visits, IC domains are monitored every 4-month by using the ICOPE Monitor app developed in collaboration with WHO. Once IC decline is confirmed, participants will have a clinical assessment and blood sampling to investigate markers of aging at the time IC declines are detected. Biospecimens include blood, urine, saliva, and dental plaque that are collected from all subjects at baseline and then, annually. Nasopharyngeal swabs and cutaneous surface samples are collected in a large subgroup of subjects every two years. Feces, hair bulb and skin biopsy are collected optionally at the baseline visit and will be performed again during the longitudinal follow up.
EXPECTED RESULTS
RESULTS
Recruitment started on October 2019 and is expected to last for two years. Bio-resources collected and explored in the INSPIRE-T cohort will be available for academic and industry partners aiming to identify robust (set of) markers of aging, age-related diseases and IC evolution that could be pharmacologically or non-pharmacologically targetable. The INSPIRE-T will also aim to develop an integrative approach to explore the use of innovative technologies and a new, function and person-centered health care pathway that will promote a healthy aging.
Identifiants
pubmed: 33575699
doi: 10.14283/jfa.2020.38
pmc: PMC7352084
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110-120Déclaration de conflit d'intérêts
All authors of the paper “The INSPIRE research initiative: a program for GeroScience and healthy aging research going from animal models to humans and the healthcare system” declare no Conflicts of Interest related to this manuscript.
Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Nat Rev Endocrinol. 2020 May;16(5):263-275
pubmed: 32161396
Aging Cell. 2020 Feb;19(2):e13080
pubmed: 31833194
J Prev Alzheimers Dis. 2020;7(3):197-198
pubmed: 32463074
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):238-244
pubmed: 27897430
Geroscience. 2018 Dec;40(5-6):419-436
pubmed: 30151729
EMBO Mol Med. 2019 Dec;11(12):e10234
pubmed: 31746100
J Prev Alzheimers Dis. 2020;7(1):2-3
pubmed: 32010917
J Nutr Health Aging. 2020;24(4):364-365
pubmed: 32242202
J Am Geriatr Soc. 2019 Sep;67(9):1934-1939
pubmed: 31287934
Calcif Tissue Int. 2019 Jul;105(1):1-14
pubmed: 30972475
J Frailty Aging. 2020;9(1):4-8
pubmed: 32150207
J Gerontol Nurs. 2004 Nov;30(11):5-12
pubmed: 15575186
Neurology. 1988 Jun;38(6):900-3
pubmed: 3368071
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
J Am Diet Assoc. 2009 Jun;109(6):1031-41
pubmed: 19465185
J Prev Alzheimers Dis. 2020;7(1):56-64
pubmed: 32010927
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
J Nutr Health Aging. 2020;24(5):459-460
pubmed: 32346679
J Prev Alzheimers Dis. 2020;7(2):68-69
pubmed: 32236393
Nutr Rev. 1996 Jan;54(1 Pt 2):S59-65
pubmed: 8919685
Nat Rev Drug Discov. 2017 Oct;16(10):718-735
pubmed: 28729727
J Frailty Aging. 2021;10(2):86-93
pubmed: 33575696
J Alzheimers Dis. 2017;60(2):427-437
pubmed: 28854503
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Gerontologist. 2013 Apr;53(2):255-67
pubmed: 22613940
J Prev Alzheimers Dis. 2020;7(2):70-74
pubmed: 32236394
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Am Geriatr Soc. 2019 Sep;67(9):1779-1781
pubmed: 31287924
J Prev Alzheimers Dis. 2018;5(3):165-167
pubmed: 29972207
Acta Neurol Belg. 1990;90(4):207-17
pubmed: 2124031
Nat Med. 2020 Jan;26(1):83-90
pubmed: 31932806
J Prev Alzheimers Dis. 2019;6(3):169-173
pubmed: 31062827
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941